Deerfield Private Design Fund IV, L.P.'s Net Worth

$1.94 Billion

Estimate Recalculated Feb 27, 2024 06:39PM EST

Who is Deerfield Private Design Fund IV, L.P.?

Deerfield Private Design Fund IV, L.P. has an estimated net worth of $1.94 Billion. This is based on reported shares across multiple companies, which include Oncology Institute, Inc., Nkarta, Inc., Revolution Medicines, Inc., Singular Genomics Systems, Inc., Edgewise Therapeutics, Inc., Nuvalent, Inc., Mirum Pharmaceuticals, Inc., ARVINAS INC., Schrodinger, Inc., AdaptHealth Corp., Larimar Therapeutics, Inc., PROTEON THERAPEUTICS INC, Cabaletta Bio, Inc., Annexon, Inc., Frequency Therapeutics, Inc., and ARS Pharmaceuticals, Inc..

SEC CIK

Deerfield Private Design Fund IV, L.P.'s CIK is 0001680307

Past Insider Trading and Trends

2021 was Deerfield Private Design Fund IV, L.P.'s most active year for acquiring shares with 27 total transactions. Deerfield Private Design Fund IV, L.P.'s most active month to acquire stocks was the month of June. 2021 was Deerfield Private Design Fund IV, L.P.'s most active year for disposing of shares, totalling 20 transactions. Deerfield Private Design Fund IV, L.P.'s most active month to dispose stocks was the month of June. 2019 saw Deerfield Private Design Fund IV, L.P. paying a total of $140,679,996.00 for 18,708,852 shares, this is the most they've acquired in one year. In 2021 Deerfield Private Design Fund IV, L.P. cashed out on 139,014,036 shares for a total of $2,656,549.79, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Oncology Institute, Inc. (TOI) Snapshot price: $2.18

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
85.15K
85.15K
Nov 12
Form 4
5M
$10.00
$50,000,000.00
5M
Mar 13
Form 3
0
0
No matching records found

Nkarta, Inc. (NKTX) Snapshot price: $10.2

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.42M
$18.00
2.42M
Jul 14
Form 3
0
0
No matching records found

Revolution Medicines, Inc. (RVMD) Snapshot price: $30.25

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.1M
$17.00
2.1M
Feb 18
Form 3
0
0
No matching records found

Singular Genomics Systems, Inc. (OMIC) Snapshot price: $0.62

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
9.11M
$19.99
$33,257,804.80
9.11M
Jun 1
Form 3
0
0
No matching records found

Edgewise Therapeutics, Inc. (EWTX) Snapshot price: $19.81

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3.93M
$16.00
3.93M
Mar 30
Form 3
0
0
No matching records found